- Toxicology
- Quinazoline and Quinoline Derivatives
- Salts and Derivatives of Active Pharmaceutical Ingredients (API)
Product Information
- 4-(Trifluoromethoxy)-benzenamine
- (4-(Trifluoromethoxy)phenyl)amine
- 1-Amino-4-(trifluoromethoxy)benzene
- 4-(Trifluoromethoxy)benzenamine
- 4-Trifluoromethoxybenzeneamine
- 4-[(Trifluoromethyl)oxy]aniline
- p-(Trifluoromethoxy)aniline
- p-Trifluoromethoxyphenylamine
- p-Anisidine
- α,α,α-trifluoro- (6CI,7CI,8CI)
- α,α,α-Trifluoro-p-anisidine
Stability Hygroscopic
Applications 4-(Trifluoromethoxy)aniline is used in the synthesis of anticancer agents and antitumor medicaments. Also, its an intermediate in the production of labelled Riluzole (R510000), a neuroprotective agent. Modulates glutamatergic transmission. A glutamate release inhibitor. An anticonvulsant.
Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package
References Cilibrizzi, A., et al.: J. Med. Chem., 52, 5044 (2009), Verhaeghe, P., et al.: Bioorg. Med. Chem., 17, 4313 (2009), Chandregowda, V., et al.: Eur. J. Med. Chem., 44, 3046 (2009), Wahl, F., et al.: Eur. J. Pharmacol., 230, 209 (1993) Bensimon, G., et al.: N. Engl. J. Med., 330, 585 (1994); Piras, S. et al.: Eur. j. Med. Chem., 75, 169 (2014); Vyas, V. et al.: Eur. J. Med. Chem., 82, 385 (2014);
Chemical properties
Technical inquiry about: 4-(Trifluoromethoxy)aniline
Please use instead the cart to request a quotation or an order
